| Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum β-lactamase in a large US medical center K Hayakawa, S Gattu, D Marchaim, A Bhargava, M Palla, K Alshabani, ... Antimicrobial agents and chemotherapy 57 (8), 4010-4018, 2013 | 110 | 2013 |
| Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia K Hayakawa, D Marchaim, ET Martin, N Tiwari, A Yousuf, B Sunkara, ... Antimicrobial agents and chemotherapy 56 (5), 2452-2458, 2012 | 64 | 2012 |
| Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin T Judge, JM Pogue, D Marchaim, K Ho, S Kamatam, S Parveen, N Tiwari, ... Infection Control & Hospital Epidemiology 33 (12), 1250-1254, 2012 | 32 | 2012 |
| Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control study K Hayakawa, D Marchaim, JM Pogue, K Ho, S Parveen, P Nanjireddy, ... American Journal of Infection Control 40 (10), e261-e263, 2012 | 19 | 2012 |
| Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes PM Nanjireddy, SH Olejniczak, NP Buxbaum Frontiers in Immunology 14, 1121565, 2023 | 13 | 2023 |
| Acute hepatic encephalopathy and multiorgan failure in sickle cell disease and COVID‐19 GM Martone, PM Nanjireddy, RA Craig, AJ Prout, MA Higman, KM Kelly, ... Pediatric Blood & Cancer 68 (5), 2021 | 7 | 2021 |
| Current Epidemiology and Clinical Impact of Extended-Spectrum â-Lactamase-Producing Escherichia coli at a Tertiary Medical Center K Hayakawa, D Marchaim, A Bhargava, MB Palla, K Alshabani, U Mahesh, ... American Journal of Infection Control 40 (5), e65-e67, 2012 | | 2012 |
